266 related articles for article (PubMed ID: 9356018)
1. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
Kahn SE; Halban PA
Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
[TBL] [Abstract][Full Text] [Related]
2. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
3. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Røder ME; Porte D; Schwartz RS; Kahn SE
J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
[TBL] [Abstract][Full Text] [Related]
4. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
Røder ME; Schwartz RS; Prigeon RL; Kahn SE
J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
[TBL] [Abstract][Full Text] [Related]
5. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus.
Røder ME; Vaag A; Hartling SG; Dinesen B; Lanng S; Beck-Nielsen H; Binder C
J Clin Endocrinol Metab; 1995 Aug; 80(8):2359-63. PubMed ID: 7629230
[TBL] [Abstract][Full Text] [Related]
7. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
[TBL] [Abstract][Full Text] [Related]
8. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
9. Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.
Cooper MB; Tan KC; Hales CN; Betteridge DJ
Diabet Med; 1996 Sep; 13(9):816-27. PubMed ID: 8891457
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin and its conversion intermediates in human pancreas and isolated islet tissue: kinetics and steady-state analysis.
Hou X; Ling Z; Zambre Y; Foriers A; Houssa P; Deberg M; Sodoyez JC; Hales CN; Van der Auwera BJ; Pipeleers D; Van Schravendijk C
Pancreas; 1997 Aug; 15(2):113-21. PubMed ID: 9260195
[TBL] [Abstract][Full Text] [Related]
11. Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis).
Leibowitz G; Weintrob N; Pikarsky A; Josefsberg Z; Landau H; Glaser B; Hales CN; Cerasi E
Diabetologia; 1996 Nov; 39(11):1338-44. PubMed ID: 8933002
[TBL] [Abstract][Full Text] [Related]
12. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
Haffner SM; Gonzalez C; Mykkänen L; Stern M
Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
[TBL] [Abstract][Full Text] [Related]
13. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity--clinical research center study.
Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstrom RW; Fujimoto WY
J Clin Endocrinol Metab; 1995 Apr; 80(4):1399-406. PubMed ID: 7714116
[TBL] [Abstract][Full Text] [Related]
14. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.
Rhodes CJ; Lincoln B; Shoelson SE
J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623
[TBL] [Abstract][Full Text] [Related]
15. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.
Furuta M; Carroll R; Martin S; Swift HH; Ravazzola M; Orci L; Steiner DF
J Biol Chem; 1998 Feb; 273(6):3431-7. PubMed ID: 9452465
[TBL] [Abstract][Full Text] [Related]
16. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
[TBL] [Abstract][Full Text] [Related]
18. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
[TBL] [Abstract][Full Text] [Related]
19. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
[TBL] [Abstract][Full Text] [Related]
20. Insulin deficiency in non-insulin-dependent diabetes.
Temple RC; Carrington CA; Luzio SD; Owens DR; Schneider AE; Sobey WJ; Hales CN
Lancet; 1989 Feb; 1(8633):293-5. PubMed ID: 2563455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
